Trial intelligence / Profile preview

Ezetimibe efficacy and tolerability in cardiac transplant recipients taking cyclosporin

2006-005565-18Phase 4Completed

Sponsor
Manchester University NHS Foundation Trust
Start
Aug 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in hyperlipidemia comparing Ezetimibe with Placebo (2 arms). Primary endpoints: % change in total cholesterol at 6 months, % change in LDL cholesterol at 6 months and 1 more. Started Aug 2011; status: completed.

02

Drugs

ezetimibe
03

Conditions

hyperlipidemia

Beyond the preview

Go deeper on 2006-005565-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005565-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call